Lexicon Pharmaceuticals
LXRX
#7133
Rank
C$0.88 B
Marketcap
C$1.98
Share price
-4.05%
Change (1 day)
2.84%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2026 (TTM): C-$0.21

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is C-$0.21. In 2025 the company made an earnings per share (EPS) of C-$0.20 an increase over its 2024 EPS that were of C-$0.89.

EPS history for Lexicon Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$0.217.3%
2025C-$0.20-78.13%
2024C-$0.89-20%
2023C-$1.1231.15%
2022C-$0.85-0%
2021C-$0.8510.91%
2020C-$0.77-145.08%
2019C$1.70-206.09%
2018C-$1.61-5.74%
2017C-$1.70-10.95%
2016C-$1.912640%
2015C-$0.06987-96.34%
2014C-$1.91-2.53%
2013C-$1.96-9.09%
2012C-$2.15

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
C$26.02-12,513.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
C$7.56-3,706.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
C$58.56-28,040.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
C-$8.16 3,793.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
C$13.99-6,773.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
C-$0.02795-86.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
C-$1.05 400.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$0.53-353.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
C-$40.93 19,426.67%๐Ÿ‡บ๐Ÿ‡ธ USA